acebutolol has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the case of myasthenia gravis in a 74-year-old woman, 2 weeks after acebutolol had been introduced as the sole treatment for systemic hypertension." | 7.68 | Fulminant myasthenia gravis soon after initiation of acebutolol therapy. ( Aimard, G; Charles, N; Confavreux, C, 1990) |
| "We report the case of myasthenia gravis in a 74-year-old woman, 2 weeks after acebutolol had been introduced as the sole treatment for systemic hypertension." | 3.68 | Fulminant myasthenia gravis soon after initiation of acebutolol therapy. ( Aimard, G; Charles, N; Confavreux, C, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Confavreux, C | 1 |
| Charles, N | 1 |
| Aimard, G | 1 |
1 other study available for acebutolol and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Fulminant myasthenia gravis soon after initiation of acebutolol therapy.
Topics: Acebutolol; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Electromyography; | 1990 |